What is the next step for a patient who has received 5,750 cGy (centigray) of radiation therapy out of a prescribed total dose of 7,000 cGy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Radiation Therapy Continuation for Prostate Cancer

This patient should continue with the remaining 5 fractions of radiation therapy to complete the prescribed 7,000 cGy total dose, with each remaining treatment delivering 250 cGy per fraction as currently scheduled. 1

Current Treatment Status

The patient has completed:

  • 23 of 28 prescribed fractions 1
  • 5,750 cGy delivered (82% of total prescribed dose) 1
  • 5 remaining fractions needed to reach the 7,000 cGy target 1

Rationale for Completing Full Course

For patients with prostate cancer receiving definitive radiation therapy, doses between 78 and 80+ Gy provide improved PSA-assessed disease control, particularly for intermediate- or high-risk disease. 1 The prescribed 7,000 cGy (70 Gy) falls within the evidence-based range of 75.6 to 79 Gy in conventional fractionation that demonstrates appropriate disease control. 1

The current fractionation scheme of 250 cGy per fraction is consistent with standard practice for prostate cancer with pelvic lymph node irradiation. 1

Treatment Completion Protocol

Continue daily fractions of 250 cGy until reaching 28 total fractions: 1

  • Maintain the current treatment schedule without interruption
  • Each remaining session delivers 250 cGy to the reference point (Prost_SV_Pelv) 1
  • Final cumulative dose will be 7,000 cGy as prescribed 1

Critical Monitoring During Remaining Treatment

Weekly assessment is mandatory during the remaining treatment course: 1

  • Monitor vital signs and weight at each visit 1
  • Check blood counts regularly 1
  • Assess for acute toxicity symptoms 1

Prophylactic supportive care should be maintained: 1

  • Continue antiemetics on a prophylactic basis 1
  • Provide antidiarrheal medications as needed 1
  • Ensure adequate hydration throughout treatment 1

Important Considerations

Treatment interruptions should be avoided for manageable acute toxicities. 1 Careful patient monitoring and aggressive supportive care are preferable to treatment breaks, as interruptions can compromise disease control outcomes. 1

Image-guided radiation therapy (IGRT) should be utilized for daily prostate localization to improve oncologic cure rates and reduce side effects. 1 This includes techniques such as CT, ultrasound with implanted fiducials, or electromagnetic targeting/tracking. 1

Post-Treatment Follow-Up

After completing the full 7,000 cGy course, the patient will require:

  • Regular PSA monitoring for disease control assessment 1
  • Evaluation for late toxicity effects 1
  • Continued management of any treatment-related symptoms 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.